RA

Rahil Abdul Rahim Meman

Active Director Director DIN 10391130
DIN 10391130 First appointment Nov 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Rahil Abdul Rahim Meman

Data last updated:

Rahil Abdul Rahim Meman is a Director at Lifevision Medicines Private Limited (since 2023). Lifevision Medicines Private Limited reported revenue of ₹29.2 Lakh (FY 2025).

DIN 10391130
Primary Designation Director
First Appointment 14 Nov 2023
Oldest Company Age 3 yrs
Largest company Lifevision Medicines Private Limited · ₹29.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lifevision Medicines Private Limited U86909MH2023PTC402392
Director14 Nov 20232023₹29.2 Lakh (FY 2025)Active

Board colleagues of Rahil Abdul Rahim Meman

Directorship timeline

Open interactive timeline →
Lifevision Medicines Private Limited
Premium access

Shareholding and investment profile for Rahil Abdul Rahim Meman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahil Abdul Rahim Meman

Rahil Abdul Rahim Meman currently holds 1 directorship: Lifevision Medicines Private Limited (Director, since 14 Nov 2023, revenue ₹29.2 Lakh (FY 2025)).

Rahil Abdul Rahim Meman was first appointed on 14 Nov 2023 as Director at Lifevision Medicines Private Limited.

The current boards of Rahil Abdul Rahim Meman's companies include Farooqe Ali Nasir Ali Sayyed (Lifevision Medicines Private Limited), Yaseen Mohammad Aarif Memon (Lifevision Medicines Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available